Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.55% |
| 2 | Consumer Discretionary | 0.95% |
| 3 | Financials | 0.77% |
| 4 | Healthcare | 0.67% |
| 5 | Industrials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SBDS
12226
CALL
DELISTED
Solo Brands Inc
SBDS
| $8.5K | ﹤0.01% |
1,250
-560
| -31% | -$17.2K |
|
12227
Clean Energy Technologies
CETY
$12.2M
| $8.49K | ﹤0.01% |
1,156
-172
| -13% | -$1.32K |
|
12228
PUT
Smith Micro Software
SMSI
$16.6M
| $8.47K | ﹤0.01% |
+2,320
| New | +$14K |
|
12229
iPower
IPW
$452K
| $8.34K | ﹤0.01% |
+8
| New | +$11.8K |
|
|
FURY
12230
Fury Gold Mines
FURY
$122M
| $8.1K | ﹤0.01% |
20,502
-50,714
| -71% | -$19.7K |
|
12231
CEL-SCI Corp
CVM
$26M
| $7.85K | ﹤0.01% |
1,135
-1,561
| -58% | -$16.9K |
|
12232
Emerson Radio
MSN
$9.78M
| $7.34K | ﹤0.01% |
+16,418
| New | +$7.75K |
|
12233
CALL
Talphera
TLPH
$63.8M
| $7.25K | ﹤0.01% |
14,500
-40,200
| -73% | -$24.5K |
|
|
ATMCR
12234
DELISTED
AlphaTime Acquisition Corp Right
ATMCR
| $7.23K | ﹤0.01% |
+45,073
| New | +$7.5K |
|
12235
Solidion Technology
STI
$62.6M
| $7.17K | ﹤0.01% |
1,190
-3,747
| -76% | -$65.1K |
|
12236
Biomerica
BMRA
$5.47M
| $7.1K | ﹤0.01% |
1,566
-2,112
| -57% | -$10.4K |
|
|
FRSX
12237
Foresight Autonomous Holdings
FRSX
$4.91M
| $6.75K | ﹤0.01% |
494
-3,530
| -88% | -$72.5K |
|
12238
Genius Group
GNS
$34.4M
| $6.73K | ﹤0.01% |
28,268
-35,409
| -56% | -$15.8K |
|
|
OPI
12239
CALL
DELISTED
Office Properties Income Trust
OPI
| $6.72K | ﹤0.01% |
14,600
-1,500
| -9% | -$1.28K |
|
|
CISO
12240
CISO Global
CISO
$10.2M
| $6.66K | ﹤0.01% |
15,030
| – | – |
|
|
ABVE
12241
DELISTED
Above Food Ingredients Inc
ABVE
| $6.61K | ﹤0.01% |
+11,146
| New | +$5.5K |
|
|
12242
CALL
Biomerica
BMRA
$5.47M
| $6.61K | ﹤0.01% |
+1,450
| New | +$7.17K |
|
12243
PUT
Lexicon Pharmaceuticals
LXRX
$1.04B
| $6.58K | ﹤0.01% |
14,300
+3,500
| +32% | +$2.21K |
|
|
ATMVR
12244
DELISTED
AlphaVest Acquisition Corp Right
ATMVR
| $6.55K | ﹤0.01% |
29,743
+17,113
| +135% | +$2.92K |
|
|
CBIO
12245
Crescent Biopharma
CBIO
$631M
| $6.42K | ﹤0.01% |
306
-102
| -25% | -$2.73K |
|
12246
American Resources Corp
AREC
$291M
| $6.34K | ﹤0.01% |
13,576
-26,345
| -66% | -$16.2K |
|
12247
CALL
ALX Oncology
ALXO
$277M
| $6.26K | ﹤0.01% |
10,100
-5,300
| -34% | -$6.36K |
|
|
SDEV
12248
Stablecoin Development Corp
SDEV
$52.6M
| $6.18K | ﹤0.01% |
+2,112
| New | +$6.86K |
|
|
12249
PUT
CEL-SCI Corp
CVM
$26M
| $6K | ﹤0.01% |
870
-1,083
| -55% | -$11.7K |
|
|
WGSWW
12250
DELISTED
GeneDx Holdings Warrant
WGSWW
| $5.92K | ﹤0.01% |
+28,177
| New | +$6.31K |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass withdrew a net $24.4B in Q1 2025, closing 1,482 positions and reducing 4,842 holdings. Its most notable exit was Inari Medical, Inc. Common Stock, an estimated $24M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 2% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jeff Yass opened a new position in Brookfield Asset Management worth $86M.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.